← FDA DRUG APPROVALS
FDA ANDA · ANDA217087
MINZOYA
levonorgestrel and ethinyl estradiol and ferrous bisglycinate
Sponsor: LUPIN
APPLICATION
ANDA217087
TYPE
ANDA
ORIGINAL APPROVAL
2024-02-15
LATEST ACTION
2024-02-15
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
MINZOYAPrescription
ETHINYL ESTRADIOL 0.02MG, LEVONORGESTREL 0.1MG · TABLET · ORAL
Approval history
2024-02-15UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.